The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infection

[1]  P. Steinberger,et al.  A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR , 2022, The Journal of experimental medicine.

[2]  D. Montefiori,et al.  Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species , 2022, PLoS pathogens.

[3]  Oscar J. Pellicer-Valero,et al.  Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study , 2022, International Journal of Infectious Diseases.

[4]  Peter D. Crompton,et al.  Repeated Plasmodium falciparum infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire , 2021, Science Translational Medicine.

[5]  S. Mostafavi,et al.  Characterization of Adaptive-like γδ T Cells in Ugandan Infants during Primary Cytomegalovirus Infection , 2021, Viruses.

[6]  S. Kent,et al.  Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection , 2021, medRxiv.

[7]  R. Veazey,et al.  Dysregulation of IL-17/IL-22 Effector Functions in Blood and Gut Mucosal Gamma Delta T Cells Correlates With Increase in Circulating Leaky Gut and Inflammatory Markers During cART-Treated Chronic SIV Infection in Macaques , 2021, Frontiers in Immunology.

[8]  A. Maghazachi,et al.  Chemokines and chemokine receptors during COVID-19 infection , 2021, Computational and Structural Biotechnology Journal.

[9]  Xueyan Xi,et al.  Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling , 2020, Virology journal.

[10]  D. Lauffenburger,et al.  Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques , 2020, Nature.

[11]  T. Geisbert,et al.  Establishment of an African green monkey model for COVID-19 and protection against reinfection , 2020, Nature immunology.

[12]  M. Keshavarz,et al.  Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches , 2020, Virology Journal.

[13]  A. Andiappan,et al.  Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19 , 2020, Nature Communications.

[14]  Lisa E. Gralinski,et al.  Animal models for COVID-19 , 2020, Nature.

[15]  M. Si-Tahar,et al.  Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients , 2020, The Journal of experimental medicine.

[16]  D. Cummings,et al.  Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries , 2020, medRxiv.

[17]  M. Malim,et al.  Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.

[18]  Aaron M. Rosenfeld,et al.  Comprehensive mapping of immune perturbations associated with severe COVID-19 , 2020, Science Immunology.

[19]  A. Ganser,et al.  Reappearance of effector T cells is associated with recovery from COVID-19 , 2020, EBioMedicine.

[20]  T. Cook,et al.  Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies , 2020, Anaesthesia.

[21]  B. Zhu,et al.  Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China , 2020, The Journal of infectious diseases.

[22]  Laura J. Simpson,et al.  A single-cell atlas of the peripheral immune response in patients with severe COVID-19 , 2020, Nature Medicine.

[23]  P. G. Choe,et al.  Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity , 2020, International Journal of Infectious Diseases.

[24]  G. Rijkers,et al.  More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells , 2020, Cellular & Molecular Immunology.

[25]  Jie Dong,et al.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.

[26]  T. Kuiken,et al.  Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model , 2020, Science.

[27]  Baojun Zhang,et al.  The phenotypic changes of γδ T cells in COVID‐19 patients , 2020, medRxiv.

[28]  Hongming Miao,et al.  Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.

[29]  M. Shi,et al.  Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients , 2020, Emerging microbes & infections.

[30]  J. Juno,et al.  γδ T‐cell responses during HIV infection and antiretroviral therapy , 2019, Clinical & translational immunology.

[31]  Y. Iwakura,et al.  Interleukin‐17‐producing γδ T (γδ17) cells in inflammatory diseases , 2018, Immunology.

[32]  David F. Boyd,et al.  Lung &ggr;&dgr; T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity , 2018, Immunity.

[33]  M. Davey,et al.  Recasting Human Vδ1 Lymphocytes in an Adaptive Role , 2018, Trends in immunology.

[34]  M. M. Nielsen,et al.  γδ T cells in homeostasis and host defence of epithelial barrier tissues , 2017, Nature Reviews Immunology.

[35]  M. Lichterfeld,et al.  The loss of CCR6+ and CD161+ CD4+ T cell homeostasis contributes to disease progression in SIV-infected rhesus macaques , 2016, Mucosal Immunology.

[36]  R. McLoughlin,et al.  Memory γδ T Cells-Newly Appreciated Protagonists in Infection and Immunity. , 2016, Trends in immunology.

[37]  N. Rout.  Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques , 2016, PloS one.

[38]  E. Adams,et al.  Human gamma delta T cells: Evolution and ligand recognition. , 2015, Cellular immunology.

[39]  T. Luedde,et al.  Chemokine receptor CCR6‐dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis , 2014, Hepatology.

[40]  Ido D. Weiss,et al.  CCR6 is required for epidermal trafficking of γδ T cells in an IL-23-induced model of psoriasiform dermatitis , 2012, The Journal of investigative dermatology.

[41]  P. Hu,et al.  Enhanced Peripheral γδT Cells Cytotoxicity Potential in Patients with HBV-Associated Acute-On-Chronic Liver Failure Might Contribute to the Disease Progression , 2012, Journal of Clinical Immunology.

[42]  E. Adams,et al.  Evolution of the V, D, and J gene segments used in the primate γδ T-cell receptor reveals a dichotomy of conservation and diversity , 2011, Proceedings of the National Academy of Sciences.

[43]  Toshihiro Ito,et al.  CCR6 as a mediator of immunity in the lung and gut. , 2011, Experimental cell research.

[44]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[45]  J. Lifson,et al.  Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques. , 2010, Blood.

[46]  L. Cosmi,et al.  CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC , 2010, European journal of immunology.

[47]  M. Goldman,et al.  Human cytomegalovirus elicits fetal γδ T cell responses in utero , 2010, The Journal of experimental medicine.

[48]  J. Christensen,et al.  CXCR3 Directs Antigen-Specific Effector CD4+ T Cell Migration to the Lung During Parainfluenza Virus Infection1 , 2009, The Journal of Immunology.

[49]  J. Peiris,et al.  Phosphoantigen-Expanded Human γδ T Cells Display Potent Cytotoxicity against Monocyte-Derived Macrophages Infected with Human and Avian Influenza Viruses , 2009, The Journal of infectious diseases.

[50]  L. Cosmi,et al.  Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.

[51]  L. Corey,et al.  γδ+ T Cells Involvement in Viral Immune Control of Chronic Human Herpesvirus 8 Infection1 , 2008, The Journal of Immunology.

[52]  M. Diamond,et al.  CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis1 , 2008, The Journal of Immunology.

[53]  J. Sung,et al.  Anti–Severe Acute Respiratory Syndrome Coronavirus Immune Responses: The Role Played by Vγ9Vδ2 T Cells , 2006, The Journal of infectious diseases.

[54]  M. Patarroyo,et al.  Functional and Structural Similarity of Vγ9Vδ2 T Cells in Humans and Aotus Monkeys, a Primate Infection Model for Plasmodium falciparum Malaria1 2 , 2001, The Journal of Immunology.